Ledger.Open graph →
SEC Form D · Amendment · filed June 16, 2014

Presidio Pharmaceuticals, Inc

Offering
$22.5M
Sold
$21.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Scott Lessing · San Francisco, CADirectorEric Ruby · San Francisco, CAExecH. Daniel Perez · San Francisco, CADirectorLeping Li · San Francisco, CAExecRichard Colonno · San Francisco, CAExecNathaniel Brown · San Francisco, CAExecLeo Redmond · San Francisco, CAExec · DirectorOmar Haffar · San Francisco, CADirectorRobert Williamson · San Diego, CADirectorBruce C. Long · EDINBURGH, SCOTLAND, United KingdomDirectorGeorge W. Browning · EDINBURGH, SCOTLAND, United KingdomExec · DirectorJoshua M. Braunfeld · New York, NYDirectorRobert Weiss · New York, NYExecKevin B. Cashen · Lutherville, MDExecByler Kerry · CHICAGO, ILDirectorAlan Krigstein · PHILADELPHIA, PAExecKwadwo O. Dodi · NEWARK, NJExecRobert Williamson · San Diego, CADirectorPamela Vig · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗